Last reviewed · How we verify

NCT03987035

BGP Stent as Bridging Stent in FEVAR

Completed NA Last updated 9 April 2025
What this trial tests

NA trial testing BeGraft Peripheral (BGP) Stent Graft System as bridging stent in Thoracoabdominal Aortic Aneurysm, Without Mention of Rupture in 103 participants. Completed in 31 August 2024.

Timeline
18 March 2021
Primary endpoint
19 July 2022
31 August 2024

Quick facts

Lead sponsorMarc Bosiers, MD
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment103
Start date18 March 2021
Primary completion19 July 2022
Estimated completion31 August 2024
Sites9 locations across Germany

Drugs / interventions tested

Conditions studied

Sponsor

Marc Bosiers, MD

Who can join

55 and older, any sex, with Thoracoabdominal Aortic Aneurysm, Without Mention of Rupture or Abdominal Aortic Aneurysm, Without Mention of Rupture. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of this clinical investigation is to evaluate, in a controlled setting, the safety and performance of the BeGraft Peripheral (BGP) balloon expandable covered stent Graft System (Bentley InnoMed, Hechingen, Germany) implanted as bridging stent in FEVAR (fenestrated endovascular aortic repair) for complex aortic aneurysms.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. GORE VIABAHN VBX Balloon-Expandable Endoprostheses as a Bridging Stent With Branched and Fenestrated Endografts in the Endovascular Treatment of Aortic Aneurysms: Protocol for a Retrospective Multicenter Registry (EMBRACE Study).
    Dioni P, Wanhainen A, Budtz-Lilly J, Dias N, et al · · 2026 · PMID 41773696 · DOI 10.2196/78970

Verify or expand the search:

Other recruiting trials for Thoracoabdominal Aortic Aneurysm, Without Mention of Rupture

Currently open trials in the same condition.

Other Marc Bosiers, MD trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03987035.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing